ABDOH, Q.; KITTANEH, A.; RABI, R.; DWEIKAT, A.; DARWISH, A.; NAJAJRA, D.; AWWAD, M.; RAJAB, I.; YAGHMOUR, R.; ALNEES, M. Risk factors for anti-infliximab antibody formation among patients with inflammatory bowel disease. MedNEXT Journal of Medical and Health Sciences, [S. l.], v. 5, n. 3, 2024. DOI: 10.54448/mdnt24305. Disponível em: https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/387. Acesso em: 22 apr. 2025.